New York State Common Retirement Fund Lyell Immunopharma, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 51,263 shares of LYEL stock, worth $29,732. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,263
Previous 51,263
-0.0%
Holding current value
$29,732
Previous $74,000
4.05%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding LYEL
# of Institutions
122Shares Held
142MCall Options Held
18.1KPut Options Held
200-
Mwg Management Ltd. Washington, DC20.2MShares$11.7 Million30.81% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$8.75 Million13.96% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$8.75 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$5.84 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $144M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...